The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder

Citation
M. Steiner et al., The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder, BR J OBST G, 108(5), 2001, pp. 462-468
Citations number
33
Language
INGLESE
art.tipo
Article
Categorie Soggetti
Reproductive Medicine","da verificare
Journal title
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
ISSN journal
1470-0328 → ACNP
Volume
108
Issue
5
Year of publication
2001
Pages
462 - 468
Database
ISI
SICI code
1470-0328(200105)108:5<462:TEOFII>2.0.ZU;2-F
Abstract
Objective To determine the effectiveness of fluoxetine in alleviating physi cal symptoms of premenstrual dysphoric disorder. Design Randomised, double-blind, placebo controlled, parallel study. Setting Canadian University based outpatient clinics. Participants Four hundred and five subjects, of whom 320 with prospectively determined premenstrual dysphoric disorder were randomised. Methods Randomised women were assigned to fluoxetine 20 or 60 mg/day or pla cebo. Common physical symptoms associated with premenstrual dysphoric disor der including breast tenderness, bloating, and headache were evaluated by v isual analog scales and the self-rated and observer premenstrual tension sy ndrome scales. Outcome measures Luteal phase change from mean baseline scores to mean trea tment scores for all scales. Results Fluoxetine treatment was statistically superior to placebo, with no significant differences between the two fluoxetine dosages in their effect s on physical symptoms. Conclusion Daily fluoxetine treatment is superior to placebo in improving t he most common physical symptoms associated with premenstrual dysphoric dis order.